These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence. Hrachovec J; Patel P Gastroenterology; 2003 Jun; 124(7):2003-4; author reply 2004-5. PubMed ID: 12812198 [No Abstract] [Full Text] [Related]
68. [Antiviral treatment in liver cirrhosis due to hepatitis C virus]. Martínez-Bauer E; Forns X Gastroenterol Hepatol; 2003 May; 26(5):303-6. PubMed ID: 12732104 [No Abstract] [Full Text] [Related]
69. [Due to normal transaminase values, no further treatment. Hepatitis C patient "suddenly" has liver cirrhosis]. MMW Fortschr Med; 2004 May; 146(19):64. PubMed ID: 15357490 [No Abstract] [Full Text] [Related]
70. [Effectiveness of long-acting interferon (peginterferon)]. Kondo Y; Tateishi R; Yoshida H; Omata M Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):515-8. PubMed ID: 15359853 [No Abstract] [Full Text] [Related]
71. [Treatment of patients with chronic hepatitis C who never had been treated]. Hézode C Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B38-49. PubMed ID: 12180307 [No Abstract] [Full Text] [Related]
72. [Combination therapy of interferon plus ribavirin for chronic hepatitis C]. Asahina Y; Izumi N Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):467-73. PubMed ID: 15359843 [No Abstract] [Full Text] [Related]